Skip to Content

Biogen CEO on Controversial Alzheimer's Drug: "There Is Hope"


CEO Michel Vounatsos says if the drug is approved it will require new payment innovations to make it affordable for the people who need it.


[MUSIC PLAYING] Michel, you surprised a lot of people recently when you announced once again that you were going to ask the FDA, the Food and Drug Administration, to approve a drug to treat Alzheimer's. And the reason why everybody was so shocked was that it was only in March that you pulled the dru...

show more